How Do I Best Evaluate Myeloma Treatment Options After Relapse?

Published on

Topics include: Treatments

What course of action should multiple myeloma patients take after a relapse? Does the nature of relapse vary from patient to patient? Experts Dr. Jonathan Kaufman, from the Winship Cancer Institute, and Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, explain what factors doctors consider when choosing treatment for relapsed myeloma and whether it’s safe to reuse the same treatment a patient had during induction therapy. Watch now to find out more. 

This town meeting is sponsored by Amgen, Janssen Pharmaceuticals and Adaptive Biotechnologies. It is produced by Patient Power in partnership with Winship Cancer Institute of Emory University.

View more programs featuring , and

Produced in association with Winship Cancer Institute

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Jack Aiello:

So, Dr. Kaufman, we talked a little bit about this, but these days it's not—it's pretty typical for a patient to have induction therapy of RVD.  They may or may not go through a transplant.  They probably will go on some type of maintenance, and then they relapse.  How do you go about deciding what treatment is next for them?  

As you mentioned before, the good news is that we have a lot of treatment options.  The challenge, if I remember this correctly, I think there are seven therapies, groups of therapies, seven regimens that are currently approved for use as treatment in the first relapse, when the myeloma comes back. And so we've spent a lot of time and energy within our group trying to place the right treatment in the right patient population at that time.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Developments in Myeloma: What Are BiTEs?

How can BiTES benefit myeloma patients? Noted myeloma expert Dr. Jonathan Kaufman explains how the immunotherapy works to treat multiple myeloma and where research is today. Watch now to find out more.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 29, 2018